This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0028480622 Reproduction Date:
InChI=1S/C22H26N4O2/c27-21-15-25(22(28)20-9-4-10-26(20)21)16-23-11-13-24(14-12-23)19-8-3-6-17-5-1-2-7-18(17)19/h1-3,5-8,20H,4,9-16H2 Y Key:CTZWGZSINBFHFD-UHFFFAOYSA-N Y
CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the phenylpiperazine class.[1] First synthesized in 2003, it was designed based on computational models and QSAR studies.[2][3] In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.[1]
: PSO/PSI
(, , , , , , ), /,
proc (/), drug (/////)
5-Methoxytryptamine, Metitepine, Lysergic acid diethylamide, Bromocriptine, Methysergide
5-Carboxamidotryptamine, Metitepine, Lysergic acid diethylamide, Bromocriptine, Methysergide
Amphetamine, Cocaine, Iron, Zinc, Methamphetamine
Metitepine, 5-Carboxamidotryptamine, 5-Methoxytryptamine, Lysergic acid diethylamide, Bromocriptine
Serotonin, Ergoline, Lysergic acid diethylamide, 5-Methoxytryptamine, Substituted tryptamine